- Home
- LASR vs ELVN Comparison
LASR vs ELVN Comparison
Compare LASR & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LASR | ELVN |
|---|---|---|
| Founded | 2000 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.3B |
| IPO Year | 2018 | 2020 |
Fundamental Metrics
Financial Performance| Metric | LASR | ELVN |
|---|---|---|
| Price | $73.36 | $45.75 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 5 |
| Target Price | ★ $54.31 | $43.40 |
| AVG Volume (30 Days) | 1.4M | ★ 1.6M |
| Earning Date | 05-07-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 62.99 | 3.17 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $191,359,000.00 | N/A |
| Revenue This Year | $10.91 | N/A |
| Revenue Next Year | $14.32 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 38.09 | N/A |
| 52 Week Low | $7.33 | $14.79 |
| 52 Week High | $74.10 | $48.53 |
Technical Indicators
Market Signals| Indicator | LASR | ELVN |
|---|---|---|
| Relative Strength Index (RSI) | 61.77 | 66.28 |
| Support Level | $51.95 | $17.48 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 4.65 | 2.44 |
| MACD | 0.90 | 0.11 |
| Stochastic Oscillator | 88.64 | 75.84 |
Price Performance
Historical ComparisonAbout LASR nLIGHT Inc.
nLight Inc is a United States-based company provider of power semiconductor and fiber lasers for aerospace and defense, industrial, and microfabrication applications. It designs, manufactures, and sells a range of power semiconductor lasers and fiber lasers that are typically integrated into laser systems. It operates in two segments: Laser Products, which includes semiconductor lasers, fiber lasers, and directed energy products; and Development segment includes revenue earned from research and development contracts. The majority of its revenue is generated from the Laser segment. The company's geographical segments include North America, Asia Pacific, and EMEA.
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.